ABBOTT LABORATORIES — Director's Dealing 2008

Jun 2, 2008

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ABBOTT LABORATORIES (ABT)
CIK: 0000001800
Period of Report: 2008-05-30

Reporting Person: LIEPMANN HOLGER A (Executive Vice President)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2008-05-30	Common shares without par value	M	13582	$44.6124	Acquired	185792	Direct
2008-05-30	Common shares without par value	F	11914	$55.96	Disposed	173878	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2008-05-30	Option (right to buy)	$44.6124	M	13582	Disposed	2011-07-08	Common shares (13582)	Direct
2008-05-30	Option (right to buy)	$55.96	A	11914	Acquired	2011-07-08	Common shares (11914)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common shares without par value	14007	Indirect
Common shares without par value	295	Indirect
Common shares without par value	296	Indirect

Footnotes

F1: Balance in the Abbott Laboratories Stock Retirement Trust as of May 29, 2008.

F2: Reporting person disclaims beneficial ownership of shares held by his daughters.

F3: Employee stock option, including a replacement option feature, granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b(3).